• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share
FOR IMMEDIATE RELEASE
July 10, 2018
Contact: HHS Press Office
202-690-6343
media@hhs.gov

Secretary Azar Statement Regarding Pfizer’s Drug Pricing Announcement

Health and Human Services Secretary Alex Azar issued the following statement today after Pfizer announced that they would defer July 1 price increases:

"Today’s announcement by Pfizer to roll back prescription drug prices in support of President Trump’s blueprint is a step in the right direction and a major win for American patients. I commend Pfizer for its constructive and professional approach, and its desire to work with President Trump to be part of the solution and not part of the problem."

"President Trump has shown strong leadership in putting American Patients First. He has made it clear that Americans are paying too much for prescription drugs and that the price increases must stop. I look forward to working with Pfizer and others who share the President’s concern for patients, and that want to work with us to lower list prices and reduce out of pocket costs."

To learn more about President Trump's blueprint to lower prescription drug prices and reduce out-of-pocket costs for American patients, please visit:
https://www.hhs.gov/about/leadership/secretary/priorities/drug-prices/index.html

###
Note: All HHS press releases, fact sheets and other news materials are available at https://www.hhs.gov/news.
Like HHS on Facebook Exit disclaimer icon, follow HHS on Twitter @HHSgov Exit disclaimer icon, and sign up for HHS Email Updates.
Last revised: July 10, 2018

Subscribe to RSS

Receive latest updates

Subscribe to our RSS